Inventor

AIGNER LUDWIG

DE9 patents

⚠️ This page may combine multiple inventors who share the name “AIGNER LUDWIG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INTELGENX CORP

2 patents

US9949934B1Apr 24, 2018

Device and method of treating conditions associated with neuroinflammation

INTELGENX CORP5 citations82

US10722476B2Jul 28, 2020

Device and method of treating conditions associated with neuroinflammation

INTELGENX CORP3 citations71

BOGDAHN ULRICH

2 patents

US8283334B2Oct 9, 2012

Inhibitors of TGF-R signaling for treatment of CNS disorders

BOGDAHN ULRICH7 citations75

US8022045B1Sep 20, 2011

Inhibitors of TGF-R-signaling for treatment of CNS disorders

BOGDAHN ULRICH5 citations67

COUILLARD-DESPRES SÉBASTIEN

2 patents

US8841430B2Sep 23, 2014

Use of regulatory sequences for specific, transient expression in neuronal determined cells

COUILLARD-DESPRES SÉBASTIEN0 citations41

US8815505B2Aug 26, 2014

Use of regulatory sequences for specific, transient expression in neuronal determined cells

COUILLARD-DESPRES SÉBASTIEN0 citations41

AIGNER LUDWIG

2 patents

US9956199B2May 1, 2018

Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders

AIGNER LUDWIG1 citations40

US9527860B2Dec 27, 2016

Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders

AIGNER LUDWIG1 citations40

HOFFMANN LA ROCHE

1 patent

US7947448B2May 24, 2011

Use of regulatory sequences for specific, transient expression in neuronal determined cells

HOFFMANN LA ROCHE17 citations85